Drug Type Monoclonal antibody |
Synonyms EPI 005, EPI005 |
Target |
Mechanism SDF-1 antagonists(C-X-C motif chemokine ligand 12 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alopecia | Discovery | KR | 19 Jun 2024 |